These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10654298)
21. Immunohistochemical staining of DNA topoisomerase IIalpha in human gliomas. Taniguchi K; Wakabayashi T; Yoshida T; Mizuno M; Yoshikawa K; Kikuchi A; Nakashima N; Yoshida J J Neurosurg; 1999 Sep; 91(3):477-82. PubMed ID: 10470824 [TBL] [Abstract][Full Text] [Related]
22. MIB-1 staining index and peritumoral brain edema of meningiomas. Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709 [TBL] [Abstract][Full Text] [Related]
23. MIB-1 staining index of pediatric meningiomas. Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550 [TBL] [Abstract][Full Text] [Related]
24. Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma. Cobb MA; Husain M; Andersen BJ; al-Mefty O J Neurosurg; 1996 Jan; 84(1):85-90. PubMed ID: 8613841 [TBL] [Abstract][Full Text] [Related]
25. Mitosin and DNA topoisomerase IIalpha: two novel proliferation markers in the prognostication of diffuse astrocytoma patient survival. Korkolopoulou P; Patsouris E; Konstantinidou AE; Christodoulou P; Thomas-Tsagli E; Kouzelis K; Angelidakis D; Rologis D; Davaris P Appl Immunohistochem Mol Morphol; 2001 Sep; 9(3):207-14. PubMed ID: 11556747 [TBL] [Abstract][Full Text] [Related]
26. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. Oya S; Kawai K; Nakatomi H; Saito N J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847 [TBL] [Abstract][Full Text] [Related]
27. DNA topoisomerase II-alpha as a proliferation marker in astrocytic neoplasms of the central nervous system: correlation with MIB1 expression and patient survival. Holden JA; Townsend JJ Mod Pathol; 1999 Dec; 12(12):1094-100. PubMed ID: 10619260 [TBL] [Abstract][Full Text] [Related]
28. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas. Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722 [TBL] [Abstract][Full Text] [Related]
29. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables. Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926 [TBL] [Abstract][Full Text] [Related]
30. Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas. Matsuno A; Nagashima T; Matsuura R; Tanaka H; Hirakawa M; Murakami M; Tamura A; Kirino T Am J Clin Pathol; 1996 Dec; 106(6):776-81. PubMed ID: 8980354 [TBL] [Abstract][Full Text] [Related]
31. MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Vankalakunti M; Vasishta RK; Das Radotra B; Khosla VK Neuropathology; 2007 Oct; 27(5):407-12. PubMed ID: 18018472 [TBL] [Abstract][Full Text] [Related]
32. Expression of human MCM6 and DNA Topo II alpha in craniopharyngiomas and its correlation with recurrence of the tumor. Xu J; Zhang S; You C; Huang S; Cai B; Wang X J Neurooncol; 2007 Jun; 83(2):183-9. PubMed ID: 17410335 [TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma. Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730 [TBL] [Abstract][Full Text] [Related]
34. Potential doubling time and tumour doubling time in meningiomas and neurinomas. Nakasu S; Nakasu Y; Nakajima M; Yokoyama M; Matsuda M; Handa J Acta Neurochir (Wien); 1996; 138(6):763-70. PubMed ID: 8836295 [TBL] [Abstract][Full Text] [Related]
35. Analyses of proliferative potential in schwannomas. Abe M; Kawase T; Urano M; Mizoguchi Y; Kuroda M; Kasahara M; Suzuki H; Kanno T Brain Tumor Pathol; 2000; 17(1):35-40. PubMed ID: 10982008 [TBL] [Abstract][Full Text] [Related]
36. Expression of DNA topoisomerase I and DNA topoisomerase II-alpha in carcinoma of the colon. Staley BE; Samowitz WS; Bronstein IB; Holden JA Mod Pathol; 1999 Apr; 12(4):356-61. PubMed ID: 10229499 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas. Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133 [TBL] [Abstract][Full Text] [Related]
38. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up. Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326 [TBL] [Abstract][Full Text] [Related]
39. Proliferative potential of meningiomas evaluated by proliferating cell nuclear antigen expression. Nakabayashi H; Sakaguchi M; Katsuyama J; Hakuba A J Neurooncol; 1995; 24(3):209-17. PubMed ID: 7595751 [TBL] [Abstract][Full Text] [Related]
40. Results of immunohistochemical staining for cell cycle regulators predict the recurrence of atypical meningiomas. Kim MS; Kim KH; Lee EH; Lee YM; Lee SH; Kim HD; Kim YZ J Neurosurg; 2014 Nov; 121(5):1189-200. PubMed ID: 25148008 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]